Suppr超能文献

人类I型干扰素受体。干扰素β特异性受体相关磷蛋白的鉴定。

The human type I interferon receptor. Identification of the interferon beta-specific receptor-associated phosphoprotein.

作者信息

Croze E, Russell-Harde D, Wagner T C, Pu H, Pfeffer L M, Perez H D

机构信息

Department of Protein Biochemistry and Biophysics, Berlex Biosciences, Richmond, California 94804, USA.

出版信息

J Biol Chem. 1996 Dec 27;271(52):33165-8. doi: 10.1074/jbc.271.52.33165.

Abstract

We used specific antibodies recognizing the receptor 1 (IFNAR1) and the recently cloned receptor 2.2 (IFNAR2.2) chains of the human type I interferon receptor complex to demonstrate that the interferon beta (IFN-beta)-specific receptor-associated phosphoprotein is IFNAR2.2 and not an unknown or additional receptor component. Immunoprecipitation experiments demonstrated that IFNAR2.2 is present in Daudi cells as a cell surface protein of approximately 90-100 kDa, which is tyrosine-phosphorylated and associated with IFNAR1, upon stimulation of cells with IFN-beta. IFNAR2.2 was not detected associated with IFNAR1 in cells stimulated with IFN-alpha, suggesting differences in receptor interaction between the two type I interferons. Both IFNAR1 and IFNAR2.2 undergo tyrosine phosphorylation upon induction by either IFN-alpha or IFN-beta. Therefore, it is unclear as to why IFNAR2.2 is not detectable in IFNAR1 immunoprecipitates in IFN-beta-treated cells. These data suggest that, although IFN-alpha and IFN-beta may utilize similar receptor chains, they interact with IFNAR1 and IFNAR2.2 in different ways.

摘要

我们使用了特异性抗体来识别人类I型干扰素受体复合物的受体1(IFNAR1)和最近克隆的受体2.2(IFNAR2.2)链,以证明干扰素β(IFN-β)特异性受体相关磷蛋白是IFNAR2.2,而非未知或额外的受体成分。免疫沉淀实验表明,在Daudi细胞中,IFNAR2.2作为一种约90-100 kDa的细胞表面蛋白存在,在用IFN-β刺激细胞后,该蛋白会发生酪氨酸磷酸化并与IFNAR1相关联。在用IFN-α刺激的细胞中未检测到IFNAR2.2与IFNAR1相关联,这表明两种I型干扰素在受体相互作用方面存在差异。IFNAR1和IFNAR2.2在受到IFN-α或IFN-β诱导后都会发生酪氨酸磷酸化。因此,尚不清楚为何在IFN-β处理的细胞中,IFNAR1免疫沉淀物中检测不到IFNAR2.2。这些数据表明,尽管IFN-α和IFN-β可能利用相似的受体链,但它们与IFNAR1和IFNAR2.2的相互作用方式不同。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验